Blue Trust’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$989K Sell
6,938
-2,762
-28% -$419K 0.01% 300
2026
Q2
$1.52M Sell
9,700
-253
-3% -$37.9K 0.02% 221
2026
Q1
$1.52M Buy
9,953
+4,343
+77% +$666K 0.02% 225
2025
Q4
$774K Buy
5,610
+847
+18% +$111K 0.01% 342
2025
Q3
$611K Buy
4,763
+78
+2% +$9.5K 0.01% 424
2025
Q2
$567K Sell
4,685
-2,154
-31% -$243K 0.01% 410
2025
Q1
$762K Sell
6,839
-247
-3% -$26.3K 0.01% 305
2024
Q4
$689K Sell
7,086
-4,046
-36% -$431K 0.01% 295
2024
Q3
$1.19M Buy
11,132
+6,839
+159% +$776K 0.02% 237
2024
Q2
$415K Buy
4,293
+2,113
+97% +$212K 0.01% 439
2024
Q1
$211K Sell
2,180
-381
-15% -$39.1K ﹤0.01% 479
2023
Q4
$261K Buy
2,561
+34
+1% +$3.28K ﹤0.01% 374
2023
Q3
$255K Buy
2,527
+773
+44% +$78.5K ﹤0.01% 375
2023
Q2
$161K Sell
1,754
-1,082
-38% -$108K ﹤0.01% 401
2023
Q1
$258K Sell
2,836
-338
-11% -$29.5K ﹤0.01% 462
2022
Q4
$241K Buy
3,174
+627
+25% +$52.8K ﹤0.01% 401
2022
Q3
$216K Buy
2,547
+303
+14% +$25.1K ﹤0.01% 340
2022
Q2
$197K Buy
+2,244
New +$197K ﹤0.01% 323

Other funds holding NVS

Blue Trust's NVS Position: Q3 2026 in Review

Blue Trust reduced its Novartis (NVS) stake by 28% in Q3 2026, selling an estimated $419K and leaving 6,938 shares worth $989K. The position accounts for 0.01% of the portfolio, ranked #300.

Blue Trust first reported a position in NVS in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.52M in Q1 2026. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Blue Trust held 6,938 shares of Novartis worth $989K as of Q3 2026.
  • Blue Trust sold 2,762 Novartis shares in Q3 2026, an estimated $419K.
  • Novartis made up 0.01% of Blue Trust's portfolio in Q3 2026, its #300 holding.
  • Blue Trust first reported a position in Novartis in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's Novartis position peaked at $1.52M in Q1 2026.
  • 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.